Climb Bio, Inc. (CLYM) Misses Q1 EPS by 16c

Climb Bio, Inc. (NASDAQ: CLYM) reported Q1 EPS of ($0.31), $0.16 worse than the analyst estimate of ($0.15).

For earnings history and earnings-related data on Climb Bio, Inc. (CLYM) click here.

You May Also Be Interested In

• Saudi Arabia Oil Pipeline Struck By Projectiles Thursday - CNN
• GTCR Is Said To Be In Talks To Buy Software Maker SPS Commerce - Bloomberg
• Cosmos Health unit secures 2.5M-unit drug manufacturing deal with Viofar